Patents Assigned to National University Corporation
-
Patent number: 11787126Abstract: A bonding system includes a supporting jig having a mounting surface on bonding substrates which are mounted, a bonding device that sandwiches and welds the bonding substrates between itself and the mounting surface, an articulated robot to which the bonding device is attached, and a control unit that controls the articulated robot and the bonding device.Type: GrantFiled: March 23, 2018Date of Patent: October 17, 2023Assignees: TOYOTA CUSTOMIZING & DEVELOPMENT CO., LTD., AISIN SEIKI KABUSHIKI KAISHA, TOYOTA JIDOSHA KABUSHIKI KAISHA, NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY, TORAY INDUSTRIES, INC., TEIJIN LIMITED, KOMATSU LTD., SUBARU CORPORATIONInventors: Kenji Furuyashiki, Hiroshi Yuchi, Satoshi Hirawaki, Yoshinori Yamamori, Takayuki Mori, Yoshihiro Iwano, Kazuaki Amaoka
-
Patent number: 11788935Abstract: A sampling apparatus 1 samples a culture medium in a bioreactor 11. A pump 21 circulates the culture medium in the bioreactor 11 via a flow path 41 by leading out the culture medium from the bioreactor 11 into the flow path 41 and introducing the culture medium from the flow path 41 into the bioreactor 11. A valve 22 is provided in the middle of the flow path 41, and switches a flow path such that the culture medium circulated in the flow path 41 flows out to a branch flow path 42 to be sampled.Type: GrantFiled: July 10, 2019Date of Patent: October 17, 2023Assignees: NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY, SHIMADZU CORPORATIONInventors: Aya Torai, Yoshihiro Matsumoto, Tomohisa Hasunuma
-
Patent number: 11789444Abstract: A movement control method for a multi-vehicle system for moving multiple vehicles to target positions individually set for the vehicles includes: acquiring first positions of the vehicles; determining control input for moving the vehicles from the first positions to second positions away from the target positions by a first distance or more while the vehicles satisfy a predetermined condition; and updating the first distance to be a shorter distance when a distance between the second position and the target position of each of the vehicles becomes equal to or more than the first distance and within an updating distance.Type: GrantFiled: October 3, 2019Date of Patent: October 17, 2023Assignees: MITSUBISHI HEAVY INDUSTRIES, LTD., NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEMInventors: Yasuo Fujishima, Kazushige Takaki, Shunichi Azuma
-
Publication number: 20230323335Abstract: The invention provides a miniaturized cytidine deaminase-containing complex for modifying DNA formed by combining a nucleic acid sequence recognition module and cytidine deaminase, wherein the nucleic acid sequence recognition module specifically binds to a target nucleotide sequence of double-stranded DNA, the cytidine deaminase is composed of an amino acid sequence composed of a region of amino acid residues at positions 30-150 of SEQ ID NO: 1, an ortholog thereof, an amino acid sequence having mutations of one or several amino acids therein, or an amino acid sequence having at least 90% similarity thereto, and the targeted site of the double-stranded DNA is modified.Type: ApplicationFiled: September 6, 2021Publication date: October 12, 2023Applicant: NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITYInventors: Keiji NISHIDA, Ang LI, Hitoshi MITSUNOBU
-
Publication number: 20230320810Abstract: A living body compressing clip 100 includes a clip body 1 with metallic arm parts 5a and 5b configured to hold a living body tissue. The clip body 1 includes compressing pieces 10 that protrude from distal end parts of the arm parts 5a and 5b in a long-side direction of the arm parts 5a and 5b. The compressing pieces 10 are formed from a flexible resin and hold a fluorescent dye. According to the living body compressing clip 100, the compressing pieces 10 causes a vascular network to collapse while holding the living body tissue by the arm parts 5a and 5b. Therefore, when the arm parts 5a and 5b hold the mucosal tissue of the tubular organ and excitation light is applied thereto, the fluorescence emitted by the compressing pieces 10 can be satisfactorily confirmed from the serosal side.Type: ApplicationFiled: November 30, 2020Publication date: October 12, 2023Applicants: NATIONAL UNIVERSITY CORPORATION KOCHI UNIVERSITY, NIREC CORPORATIONInventors: Takayuki SATO, Tetsuo SUMIDA
-
Publication number: 20230327145Abstract: A fuel flow groove formed in a fuel electrode current collector of a fuel electrode of a fuel cell includes a plurality of flow groove portions disposed in parallel, and a plurality of return groove portions connecting an end portion of one side edge portion or an end portion of the other side edge portion of the flow groove portions of two adjacent groups. Each of the return groove portions has an inner wall surface portion facing the end portion of the flow groove portions in the return groove portions. The inner wall surface portion has a curved surface shape in which a distance facing each other from the inner wall surface portion to the end portion of the flow groove portions, gradually decreases toward both end portions of the inner side wall surface portion in a direction orthogonal to an extending direction of the flow groove portions.Type: ApplicationFiled: October 14, 2020Publication date: October 12, 2023Applicants: JTEKT CORPORATION, NATIONAL UNIVERSITY CORPORATION KANAZAWA UNIVERSITYInventors: Takuya TSUJIGUCHI, Noriyasu HAYASHI, Toshiyuki SAITO, Motoo NAKAI, Atsushi KUBO, Akihiro TAKAZATO
-
Publication number: 20230324349Abstract: One mode of a method for analyzing acylcarnitine according to the present invention is a method for analyzing C5 acylcarnitine using a tandem mass spectrometer, the method including: a measurement step of performing MRM measurement on a specimen according to at least one of MRM transitions of m/z 24>187, m/z 246>57, m/z 246>41, and m/z 246>29; and a processing step of distinguishing between isovalerylcarnitine and pivaloylcarnitine which is an isomer of isovalervicarnitine in the specimen or determining whether or not C5 acylcarnitine in the specimen includes pivaloylcarnitine, using a measurement result obtained in the measurement step. This makes it possible to satisfactorily distinguish between isovalerylcarnitine and pivaloylcarnitine, which have been conventionally difficult to distinguish.Type: ApplicationFiled: August 24, 2021Publication date: October 12, 2023Applicants: Shimadzu Corporation, NATIONAL UNIVERSITY CORPORATION SHIMANE UNIVERSITYInventors: Takanari HATTORI, Jun WATANABE, Misa TANAKA, Hironori KOBAYASHI, Yoshitomo NOTSU
-
Publication number: 20230324405Abstract: An allergic disease determination method includes contacting probes selected from an allergen and a fragment thereof and a biological sample collected from a subject; detecting a reaction between the probes and an antibody contained in the biological sample; determining a type of the antibody reacted with the probes; inputting data associated with the reaction of each of the at least two types of probes with the antibody and data associated with a type of the bound antibody into a prediction model and acquiring a prediction result; and determining an allergic disease on the basis of the prediction result. The prediction model is a nonlinear model or a model having two or more explanatory variables and two or more terms, the model being created using training data associated with the reaction of at least the probes with the antibody and training data associated with the type of the bound antibody.Type: ApplicationFiled: September 6, 2021Publication date: October 12, 2023Applicants: MITSUBISHI GAS CHEMICAL COMPANY, INC., NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITYInventors: Erika SAWANO, Yuki TAKASE, Naoki SHIMOJO, Fumiya YAMAIDE, Taiji NAKANO
-
Publication number: 20230320640Abstract: A determination device includes an acquisition unit, a first determination unit, a second determination unit, and an output unit. The acquisition unit is configured to acquire a sightline direction of a user and a sightline direction of at least one facing person facing the user. The first determination unit is configured to determine whether a sightline of the user is directed to the facing person based on the sightline direction of the user acquired by the acquisition unit. The second determination unit is configured to determine whether a sightline of the facing person is directed to the user based on the sightline direction of the facing person acquired by the acquisition unit. The output unit is configured to output a feedback to the user and/or an executor based on a result of a determination of the first determination unit and a result of a determination of the second determination unit.Type: ApplicationFiled: March 30, 2023Publication date: October 12, 2023Applicants: NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY, Sumitomo Pharma Co., Ltd.Inventors: Toshiya NAKAGUCHI, Kyohei FUKUDA, Eiji SHIMIZU, Yoshiyuki HIRANO, Naomi SHIRAIWA, Yuki IKEDA, Masanori MIYAUCHI
-
Patent number: 11781254Abstract: A production method for a low molecular weight polymer suitable for a melt-blown non-woven fabric and a production device for melt-blown non-woven fabric, with which a high molecular weight polymer can be reduced in molecular weight by applying a shear force to the high molecular weight polymer without adding an additive. The low molecular weight polymer and the melt-blown non-woven fabric are produced using a continuous high shearing device that applies a shear force to the high molecular weight polymer serving as a raw material by rotation of a screw body to reduce the molecular weight of the high molecular weight polymer so as to obtain a low molecular weight polymer, and cools the low molecular weight polymer by passing the low molecular weight polymer through a passage arranged in the axial direction inside the screw body.Type: GrantFiled: December 21, 2020Date of Patent: October 10, 2023Assignees: SHIBAURA MACHINE CO., LTD., National University Corporation Kanazawa UniversityInventors: Yuya Sasai, Takafumi Sameshima, Yoshio Iizuka, Kaho Osada, Kentaro Taki
-
Patent number: 11782061Abstract: The present inventors have surprisingly found that a deoxyhypusine synthase (DHPS) gene, which was previously reported to correlate with prostate cancer and cervical cancer, is highly responsive to arteriosclerosis or digestive system cancer, whereby the gene can be used as a desired marker for arteriosclerosis or digestive system cancer. The present invention has been accomplished on the basis of this finding. Specifically, the present invention provides a method for determining arteriosclerosis or digestive system cancer, which method includes detecting expression of a deoxyhypusine synthase gene in a test sample (preferably a blood sample), and determining arteriosclerosis or digestive system cancer of a test subject from which the test sample has been obtained, on the basis of an increase in the gene expression as an index.Type: GrantFiled: November 5, 2015Date of Patent: October 10, 2023Assignees: FUJIKURA KASEI CO., LTD., National University Corporation Chiba UniversityInventors: Rika Nakamura, Hideyuki Kuroda, Go Tomiyoshi, Takaki Hiwasa, Masaki Takiguchi, Naokatsu Saeki
-
Patent number: 11780874Abstract: A nucleoside that is more practical for RNA pharmaceuticals and other applications and use thereof is represented by formula (1) or (2) below, or a salt thereof: (In formula (1), R1 represents a hydrogen atom, a hydroxyl group, a hydroxyl group in which a hydrogen atom is substituted by an alkyl group or alkenyl group, or a protected group, and in formula (2), X represents a halogen atom. In formula (1) and formula (2), R2 and R3 may be the same or different, and each represents a hydrogen atom etc., R4 represents NHR7 (in which R7 represents a hydrogen atom etc., and B represent represents any of a purine-9-yl group, 2-oxo-pyrimidin-1-yl group, substituted purine-9-yl group or substituted 2-oxo-pyrimidin-1-yl group).Type: GrantFiled: October 31, 2018Date of Patent: October 10, 2023Assignees: YAMASA CORPORATION, NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEMInventors: Yoshihito Ueno, Yusuke Maeda, Ryohei Kajino
-
Patent number: 11780948Abstract: A resin composition for forming a phase-separated structure includes a block copolymer having a block (b1) formed of a repeating structure of styrene units, the block (b1) being partially substituted with a constituent unit represented by the following General Formula (c1) and a block (b2) having a repeating structure of methyl methacrylate units.Type: GrantFiled: January 19, 2021Date of Patent: October 10, 2023Assignees: Tokyo Ohka Kogyo Co., Ltd., National University Corporation Hokkaido UniversityInventors: Ken Miyagi, Takahiro Dazai, Toshifumi Satoh, Takuya Isono, Shunma Tanaka
-
Patent number: 11780124Abstract: An apparatus for manufacturing a thermoplastic resin material, including: a mold for molding a base material containing a thermoplastic resin into a predetermined shape; and a transfer mechanism that places the base material in the mold, wherein the transfer mechanism includes a detection mechanism that detects a state of the base material, and a controlling unit that controls operation of the mold and the transfer mechanism.Type: GrantFiled: December 7, 2018Date of Patent: October 10, 2023Assignees: HONDA MOTOR CO., LTD., KADO CORPORATION, NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM, TORAY INDUSTRIES, INC., TEIJIN LIMITED, SUBARU CORPORATION, TOYOTA JIDOSHA KABUSHIKI KAISHA, KYOWA INDUSTRIAL CO., LTD.Inventors: Satoshi Hirawaki, Yoshiaki Matsumoto, Shunya Hatanaka, Takashi Kusaka, Yasunari Kuratani
-
Patent number: 11781146Abstract: The present invention provides mammalian cell expression vectors that impart to mammalian host cells an ability to produce high levels of foreign gene-derived proteins. A ubiquitously acting chromatin opening element (UCOE) is introduced into an expression vector that has a plasmid DNA integrated into a transcriptional hot spot on the chromosome of a dihydrofolate reductase gene-deficient host cell so that it allows for selection of strains that grow in hypoxanthine-thymidine (hereinafter denoted as HT)-free medium, whereby transformants will produce a protein of interest in increased amounts.Type: GrantFiled: May 13, 2019Date of Patent: October 10, 2023Assignees: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY, FUSO PHARMACEUTICAL INDUSTRIES, LTD.Inventors: Yasuhiko Suzuki, Miki Nakagawa, Yayoi Kameda, Satoru Konnai, Tomohiro Okagawa, Naoya Maekawa, Shinya Goto, Yamato Sajiki, Kazuhiko Ohashi, Shiro Murata, Yuzuru Kitahara, Keiichi Yamamoto
-
Patent number: 11784039Abstract: A method for manufacturing a gallium nitride semiconductor device includes: preparing a gallium nitride wafer; forming an epitaxial growth film on the gallium nitride wafer to provide a processed wafer having chip formation regions; perform a surface side process on a one surface side of the processed wafer; removing the gallium nitride wafer and dividing the processed wafer into a chip formation wafer and a recycle wafer; and forming an other surface side element component on an other surface side of the chip formation wafer.Type: GrantFiled: April 13, 2021Date of Patent: October 10, 2023Assignees: DENSO CORPORATION, HAMAMATSU PHOTONICS K.K., National University Corporation Tokai National Higher Education and Research SystemInventors: Jun Kojima, Chiaki Sasaoka, Shoichi Onda, Masatake Nagaya, Kazukuni Hara, Daisuke Kawaguchi
-
Publication number: 20230312689Abstract: It is an object of the present invention to provide antibodies against coronavirus (SARS-CoV-2). It is also an object of the present invention to provide a pharmaceutical composition against coronavirus infection using the antibody. According to the present invention, an antibody or antigen-binding fragment thereof that binds to the receptor-binding domain present in the spike protein of coronavirus and is capable of neutralizing the coronavirus, and a pharmaceutical composition for the prevention or treatment of coronavirus infection containing the antibody or antigen-binding fragment, are provided.Type: ApplicationFiled: July 9, 2021Publication date: October 5, 2023Applicants: NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY, The University of TokyoInventors: Shuzo MATSUSHITA, Yu KAKU, Takeo KUWATA, Yoshihiro KAWAOKA, Masaki IMAI, Seiya YAMAYOSHI
-
Publication number: 20230314354Abstract: A gas measuring device includes: a filter to which a power supply that applies a voltage or current is connected, which generates resistance heat, and which combusts a predetermined combustible gas in contact therewith; and a gas sensor configured to detect the combustible gas that has passed through the filter.Type: ApplicationFiled: March 31, 2023Publication date: October 5, 2023Applicants: SINTOKOGIO, LTD., National University Corporation TOYOHASHI UNIVERSITY OF TECHNOLOGYInventors: Manase MIZUTANI, Yoshihisa SUZUKI, Toshihiko NODA, Kazuaki SAWADA
-
Publication number: 20230314375Abstract: A gas measuring device includes: a magnetic field generation unit configured to generate a magnetic field; and a gas sensor configured to detect a gas that has passed through the magnetic field generated by the magnetic field generation unit.Type: ApplicationFiled: March 31, 2023Publication date: October 5, 2023Applicants: SINTOKOGIO, LTD., National University Corporation TOYOHASHI UNIVERSITY OF TECHNOLOGYInventors: Manase MIZUTANI, Yoshihisa SUZUKI, Toshihiko NODA, Kazuaki SAWADA
-
Publication number: 20230310367Abstract: An object of the present disclosure is at least to provide a technique for enhancing expression of a NAMPT gene. The object is achieved by a composition for enhancing NAMPT gene expression, the composition containing an equol compound as an active ingredient.Type: ApplicationFiled: September 1, 2021Publication date: October 5, 2023Applicants: DAICEL CORPORATION, KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATIONInventors: Hiroaki YAMAMOTO, Kenichi OOE, Yoshinori KATAKURA